Cargando…
Proteomics as a Tool for Biomarker Discovery
Novel technologies are now being advanced for the purpose of identification and validation of new disease biomarkers. A reliable and useful clinical biomarker must a) come from a readily attainable source, such as blood or urine, b) have sufficient sensitivity to correctly identify affected individu...
Autores principales: | Kohn, Elise C., Azad, Nilofer, Annunziata, Christina, Dhamoon, Amit S., Whiteley, Gordon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851415/ https://www.ncbi.nlm.nih.gov/pubmed/18057524 http://dx.doi.org/10.1155/2007/967023 |
Ejemplares similares
-
Shotgun Proteomics and Biomarker Discovery
por: McDonald, W. Hayes, et al.
Publicado: (2002) -
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005) -
Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project
por: Omenn, Gilbert S.
Publicado: (2004) -
Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
por: O’Connor, Kevin C., et al.
Publicado: (2006) -
Systems Biology and the Discovery of Diagnostic Biomarkers
por: Wang, Kai, et al.
Publicado: (2010)